ScreenerHero

HLN Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

NYSE · US · Consumer Defensive · Drug Manufacturers - Specialty & Generic · haleon.com
8.845USD+0.51%Mkt Cap: 38.70B $P/E: 18.33

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the As…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8
SFZN
Siegfried Holding AG
$3.47BUSDP/E 17.7

Key Statistics

Company
Market Cap38.70B USD
Enterprise Value46.58B USD
Revenue (TTM)11.15B USD
Gross Profit7.08B USD
Net Income (TTM)1.67B USD
Revenue/Share2.50 USD
Last Price8.845 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees24.5K
CountryUS
SectorConsumer Defensive
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)18.33
P/E (Forward)14.24
PEG2.07
EV/EBITDA16.36
EV/Revenue4.18
P/S3.47
P/B1.80
EPS (TTM)0.49
EPS (Forward)0.62
52W Range
8.6507% of range11.28
52W High11.28 USD
52W Low8.650 USD
Profitability
Gross Margin64.19%
Oper. Margin23.94%
EBITDA Margin25.54%
Profit Margin15.11%
ROE10.15%
ROA5.11%
Growth
Revenue Growth2.20%
Earnings Growth-4.50%
Cash Flow & Leverage
Operating CF2.63B USD
CapEx (TTM)413.00M USD
FCF Margin16.16%
FCF Yield4.66%
Net Debt7.43B USD
Net Debt/EBITDA2.61
Balance Sheet
Debt/Equity0.52
Current Ratio0.69
Quick Ratio0.51
Book Value/Sh4.88 USD
Cash/Share0.19 USD
Dividends
Fwd Div Rate0.20 USD
Trail. Div Rate0.07 USD
Div. Yield2.25%
5Y Avg Yield—
Payout Ratio40.08%
Ex-Div DateAug 14, 2026
Pay DateSep 17, 2026
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.93 USD
Upside (mean)+34.9%
Target Range10.00 USD – 13.77 USD
10.00+34.9% to mean13.77
# Analysts5
Ownership
Shares Out.4.40B
Float4.43B
Insiders0.01%
Institutions13.64%
Short Interest
Short Ratio1.9d
Short % Float0.50%
Short % Out.0.50%
Shares Short21.80M
Short (prev mo.)13.30M
Technical
SMA 509.650 (-8.3%)
SMA 2009.803 (-9.8%)
Beta0.24
S&P 52W Chg14.58%
Avg Vol (30d)17.80M
Avg Vol (10d)23.43M
Technical Indicators
RSI (14)32.0
MACD-0.2147
MACD Signal-0.1786
MACD Hist.-0.0361
BB Upper9.586 USD
BB Middle9.197 USD
BB Lower8.807 USD
BB Width8.48%
ATR (14)0.1846 USD
Vol Ratio (20d)1.04x